During 2018 Q4 the big money sentiment decreased to 1.59. That’s change of 0.76, from 2018Q3’s 2.35. 7 investors sold all, 27 reduced holdings as NanoString Technologies, Inc. ratio fall. 31 rose positions while 23 funds acquired positions. Funds hold 23.42 million shares thus 0.33% more from 2018Q3’s 23.34 million shares.
Citadel Advsr Ltd holds 0% of its capital in NanoString Technologies, Inc. (NASDAQ:NSTG) for 90,597 shs. Secor Cap Advsr Ltd Partnership accumulated 0.06% or 31,099 shs. Citigroup holds 0% or 5,454 shs. 602 are owned by Federated Invsts Pa. Grp One Trading L P accumulated 4,304 shs. Spark Invest Mgmt Ltd Com has 0.25% invested in NanoString Technologies, Inc. (NASDAQ:NSTG) for 245,000 shs. American holds 16,559 shs. Pdt Ltd Liability invested in 21,504 shs or 0.02% of the stock. Blackstone Grp Inc Limited Partnership holds 4.04M shs. The Nebraska-based Cwm Limited Liability Corporation has invested 0% in NanoString Technologies, Inc. (NASDAQ:NSTG). California State Teachers Retirement System reported 38,927 shs stake. 2.21 million were accumulated by Blackrock. Rhumbline Advisers owns 32,220 shs. Moreover, Bank & Trust Of Montreal Can has 0% invested in NanoString Technologies, Inc. (NASDAQ:NSTG) for 3,001 shs. Artisan Partners L P holds 0.01% of its capital in NanoString Technologies, Inc. (NASDAQ:NSTG) for 191,538 shs.
NanoString Technologies, Inc. had 7 sales and 0 buys since September 17, 2018. This’s net activity of $4.70 million. GRAY R BRADLEY sold $601,200 worth of NanoString Technologies, Inc. (NASDAQ:NSTG) on Wednesday, January 9. 85,823 shs were sold by Clarus Lifesciences II – L.P., worth $1.37 million on Monday, September 17. 85,823 shs were sold by GALAKATOS NICHOLAS, worth $1.37 million.
Today NanoString Technologies, Inc. (NASDAQ:NSTG) with $30.94 share price, reached 52 week high with $32.80 target or 6.00 % above. Barchart.com published the 52 week high on Mar, 11. NanoString Technologies, Inc. (NASDAQ:NSTG) has $954.08 million MC. The valuation of NASDAQ:NSTG can change by $57.24 million if our $32.80 target is reached.
The stock increased 4.76% or $1.4 during the last trading session, reaching $30.94.Currently NanoString Technologies, Inc. is uptrending after 303.46% change in last March 11, 2018. NSTG has 270,292 shares volume. The stock outperformed the S&P 500 by 299.09%.
NanoString Technologies, Inc. (NASDAQ:NSTG) Ratings Coverage
In total 4 analysts cover NanoString Technologies (NASDAQ:NSTG). “Buy” rating has 2, “Sell” are 0, while 2 are “Hold”. (NASDAQ:NSTG) has 50% bullish analysts. With $35 highest and $18 lowest PT, NanoString Technologies has $26.25 average PT or -15.16% below the current ($30.94) price. 4 are the (NASDAQ:NSTG)’s ratings reports on Mar 11, 2019 according to StockzIntelligence Inc. On Wednesday, October 10 the stock of NanoString Technologies, Inc. (NASDAQ:NSTG) earned “Equal-Weight” rating by Morgan Stanley. On Friday, March 8 Cowen & Co maintained NanoString Technologies, Inc. (NASDAQ:NSTG) with “Hold” rating. In Thursday, February 21 report Robert W. Baird maintained it with “Buy” rating and $26 target. On Friday, March 8 J.P. Morgan maintained the shares of NSTG in report with “Buy” rating.
For more NanoString Technologies, Inc. (NASDAQ:NSTG) news released recently go to: Nasdaq.com, Globenewswire.com, Globenewswire.com, Benzinga.com or Globenewswire.com. The titles are as follows: “5 Top Gainers In Healthcare Sector (ATOS, AZRX, NSTG…) – Nasdaq” released on January 09, 2019, “NanoString to Present at the 39th Annual Cowen Healthcare Conference – GlobeNewswire” on March 04, 2019, “NanoString to Present at the Evercore ISI HEALTHCONx Conference – GlobeNewswire” with a publish date: November 20, 2018, “Earnings Scheduled For March 7, 2019 – Benzinga” and the last “Factors of Influence in 2019, Key Indicators and Opportunity within Wayfair, Valero Energy, Barrick Gold, US Silica, NanoString Technologies, and Pzena Investment Management — New Research Emphasizes Economic Growth – GlobeNewswire” with publication date: February 27, 2019.
NanoString Technologies, Inc. develops, makes, and sells life science tools for translational research and molecular diagnostic products worldwide.The firm is valued at $954.08 million. The firm offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system.Last it reported negative earnings. It provides nCounter MAX and FLEX systems that include nCounter Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples through the images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.